• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Daiwa ETF TOPIX-17 Pharmaceutical

+ Add to Watchlist

1638:JP

15,880.0000 JPY 10.0000 0.06%

As of 21:12:31 ET on 08/31/2014.

Snapshot for Daiwa ETF TOPIX-17 Pharmaceutical (1638)

Open: 15,880.0000 High - Low: 15,880.0000 - 15,880.0000 Primary Exchange: Tokyo
Volume: 6 52-Week Range: 12,830.0000 - 15,890.0000 Beta vs TP17PHRM: 0.8961

ETF Chart for 1638

No chart data available.
  • 1638:JP 15,880.0000
  • 1D
  • 1M
  • 1Y
15,890.0000
Interactive 1638 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1638

Daiwa ETF TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated i n Japan. The objective of the Fund is to provide investment results that c orrespond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-07-23 Telephone: -
Managers: -
Web Site: www.daiwa-am.co.jp

Fundamentals for 1638

NAV (on 2014-09-02) 15,968.0000
Assets (M) (on 2014-09-02) 451.0000
Shares out (M) 0.03
Market Cap (M) 448.53
% Premium -0.99
Average 52-Week % Premium -0.2894
Fund Leveraged N

Dividends for 1638

Dividend Type Distribution
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-07-16) 180.0000
Dividend Yield (ttm) 2.22%

Performance for 1638

1-Month +3.05% 1-Year -
3-Month +11.59% 3-Year +22.09%
Year To Date +9.68% 5-Year +10.46%
Expense Ratio 0.18

Top Fund Holdings for 1638

Filing Date: 06/30/2014
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 20,400 95,859,600 22.512%
Astellas Pharma Inc 62,000 82,522,000 19.380%
Otsuka Holdings Co Ltd 10,800 33,912,000 7.964%
Daiichi Sankyo Co Ltd 17,100 32,319,000 7.590%
Eisai Co Ltd 6,700 28,434,800 6.678%
Ono Pharmaceutical Co Ltd 2,500 22,300,000 5.237%
Shionogi & Co Ltd 8,500 17,969,000 4.220%
Chugai Pharmaceutical Co Ltd 5,400 15,417,000 3.621%
Santen Pharmaceutical Co Ltd 2,000 11,400,000 2.677%
Taisho Pharmaceutical Holdings 1,300 9,607,000 2.256%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil